Daily-Dose Consensus Interferon and Ribavirin: Efficacy of Combined Therapy

Clinical trial NCT00162734 · COMPLETED

Trial details

NCT number: NCT00162734
Sponsor: Bausch Health Americas, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2005-02-01
Primary completion: 2007-06-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.